Bradykinin B2 receptor antagonist FR173657 ameliorates small bowel ischemia-reperfusion injury in dogs

Digestive Diseases and Sciences

Volumn 50, Issue 1, 2005, Pages 27-36

  Arakawa, Kazuhisa ^a   Takeyoshi, Izumi ^a   Akao, Yoshihiko ^a   Totsuka, Osamu ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Bradykinin B2 receptor antagonist; FR173657; Ischemia reperfusion injury; Small intestine

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 6 OXOPROSTAGLANDIN F1 ALPHA; THROMBOXANE B2; BRADYKININ B2 RECEPTOR; QUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOG; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; INTESTINE ISCHEMIA; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SUPERIOR MESENTERIC ARTERY; TISSUE BLOOD FLOW; VASODILATATION; ANIMAL; BLOOD; BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; HEMODYNAMICS; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PH; REPERFUSION INJURY; SMALL INTESTINE; VASCULARIZATION;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; DOGS; FEMALE; HEMODYNAMIC PROCESSES; HYDROGEN-ION CONCENTRATION; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MESENTERIC ARTERY, SUPERIOR; QUINOLINES; RECEPTOR, BRADYKININ B2; REGIONAL BLOOD FLOW; REPERFUSION INJURY; THROMBOXANE B2;

EID: 14544286012     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-1273-1     Document Type: Article

References (37)

1. Welboum CRB, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischemia-reperfusion injury: Central role of the neutrophil. Br J Surg 78:651-655, 1991
2. Nilsson UA, Schoenberg MH, Aneman A, Poch B, Magadum S, Berger HG, Lundgren O: Free radicals and pathogenesis during ischemia and reperfusion of the cat small intestine. Gastroenterology 100:629-636, 1994
3. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI: Evidence for tumor necrosis factor induced pulmonary microvascular injury after intestinal ischemia-reperrusion injury. Ann Surg 212:694-700, 1990
4. Kanwar S, Teppermean BL, Payne D, Sutherland LR, Kubes P: Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock 42:135-140, 1994
5. Mangino MJ, Anderson CB, Murphy MK, Brunt E, Turk J: Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury. Am J Physiol 257:G299-G307, 1989
6. 4 in the granulocyte infiltration into postischemic feline intestine. Gastroenterology 99:1358-1363, 1990
7. Ernster L: Biochemistry of reoxygenation injury. Crit Care Med 16:947-953, 1988
8. 2. Proc Natl Acad Sci USA 84:6374-6378, 1987
9. 2 in bovine pulmonary artery endothelial cells. Agents Actions 40:110-118, 1993
10. 2 and C. J Biol Chem 263:14640-14647, 1988
11. Bathon JM, Proud D: Bradykinin antagonists. Annu Rev Pharmacol Toxicol 31:129-162, 1991
12. 2 receptor preserves microcirculation in experimental pancreatitis in rats. Am J Physiol 274:G42-G51, 1998
13. Hoffmann TF, Leiderer R, Waldner H, Messmer K: Bradykinin antagonists HOE-140 and CP-0597 diminish microcirculatory injury after ischaemia-reperfusion of the pancreas in rats. Br J Surg 83:189-195, 1996
14. 2 receptor antagonist, FR173657, on pulmonary ischemia-reperfusion injuiy in dogs. J Heart Lung Transplant 21:1022-1029, 2002
15. Iwanami K, Takeyoshi I, Ohwada S, Kobayashi J, Kawata K, Matsumoto K, Morishita Y: Intramucosal pH and intestinal mucosal damage in ischemia-reperfusion injury. Transplant Int 11:401-407, 1998
16. Chiu C-J, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101:478-483, 1970
17. Parks DA, Bulkley GB, Granger DN, Hamilton SR, McCord JM: Ischemic injury in the cat small intestine: Role of superoxide radicals. Gastroenterology 82:9-15, 1982
18. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology 81:22-29, 1981
19. Schoenberg MH, Muhl E, Sellin D, Younes M, Schildberg FW, Hagland U: Posthypotensive generation of superoxide free radicals: Possible role in the pathogenesis of the intestinal mucosal damage. Acta Chir Scand 150:301-309, 1984
20. Takahashi T, Kunimoto F, Ichikawa H, Ishikawa S, Sato Y, Hasegawa Y, Morishita Y: Gastric intramucosal pH and hepatic venous oximetry after cardiopulmonary bypass in valve replacement patients. Cardiovasc Surg 4:308-310, 1996
21. Wolfard A, Vangel R, Szalay L, Kaszaki J, Haulik L, Balogh A, Nagy S, Boros M: Endothelin-A receptor antagonism improves small bowel graft perfusion and structure after ischemia and reperfusion. Transplantation 68:1231-1238, 1999
22. Kubes P: Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 262:G1138-G1142, 1992
23. Marceau F: Kinin B1 receptors: A review. Immunopharmacology 30:1-26, 1995
24. 2 receptor antagonist, FR173657. Br J Pharmacol 120:617-624, 1997
25. Ryan JW, Moffat JG, Thompson AG: Role of bradykinin in the development of acute pancreatitis. Nature 204:1212-1213, 1964
26. Ryan JW, Moffat JG, Thompson AG: Role of bradykinin system in acute hemorrhagic pancreatitis. Arch Surg 91:14-24, 1965
27. Yotsumoto F, Manabe T, Ohshio G: Bradykinin involvement in the aggravation of acute pancreatitis in rabbits. Digestion 54:224-230, 1993
28. Elliott DF, Horton EW, Lewis GP: Actions of pure bradykinin. J Physiol 153:473-480, 1960
29. Kunze H, Vogt W: Significance of phospholipase A for prostaglandin formation. Ann NY Acad Sci 180:123-125, 1971
30. Hamgerg M, Samuelsson B: Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71:3400-3404, 1974
31. Moncada S, Vane JR: Arachidonic acid metabolites and interactions between platelets and blood vessel walls. N Engl J Med 300:1142-1147, 1979
32. Kaplan E, Diehl JT, Peterson MB, Somerville KH, Daly BDT, Connolly RJ, Cooper AG, Seiler SD, Cleveland RJ: Extended ex vivo preservation of the heart and lungs. Effects of acellular oxygen-carrying perfusates and indomethacin on the autoperfused working heart-lung preparation. J Thorac Cardiovasc Surg 100:687-698, 1990
33. Isozaki H, Okajima K, Hara H, Kobayashi M: The protective effect of thromboxane AT synthetase inhibitor against ischemic liver injury. Surg Today 24:435-440, 1994
34. 2 balance: Pathophysiological and therapeutic implications. Br Med Bull 39:271-276, 1983
35. 2 synthesis inhibitor OKY046. Transplantation 62:879-883, 1996
36. Okada Y, Marchevsky AM, Kass RM, Matloff JM, Jordan SC: A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation. Transplantation 66:1132-1136, 1998
37. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K: Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 87:2036-2041, 1991.